Notable Investors / Q4 2023
David Einhorn’s Portfolio — GREENLIGHT CAPITAL INC
President, Greenlight Capital
CIK 0001079114 · Part of the Greenlight family · 140 EAST 45TH STREET, 24TH FLOOR, NEW YORK, NY, 10017 · 2129731900
About David Einhorn
David Einhorn founded Greenlight Capital and made his name with forensic short calls — most famously Lehman Brothers before its collapse and Allied Capital before that. He is equally known for disciplined long-side value investing and, lately, for arguing that value investing's institutional buyer base has structurally shrunk.
Greenlight's 13F skews toward deeply out-of-favor value: housing-related names, industrials, and special situations, typically at single-digit price-to-earnings multiples. Positions are sized with conviction and held through long stretches of market indifference.
Portfolio data below is from GREENLIGHT CAPITAL INC’s SEC 13F filings. View the full filer page →
Summary
Greenlight Capital Inc reported $2.0B in U.S.-listed holdings across 116 positions for Q4 2023.
Its largest position, GRBK, represents 19.9% of the portfolio.
Compared with Q3 2023, the fund opened 7 new positions and exited 6.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 84.6% · $1.7B
- Other · 9.4% · $192M
- ETP · 5.6% · $114M
- ADR · 0.5% · $9M
- Equity WRT · 0.0% · $6,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ALITEURALIGHT INC | NEW | +9.24M | 9.24M | +$79M | $79M |
| VTRSVIATRIS INC | NEW | +3.36M | 3.36M | +$36M | $36M |
| AERCAP HOLDINGS NV | NEW | +250.0K | 250.0K | +$19M | $19M |
| SPDR SER TR | NEW | +129.7K | 129.7K | +$18M | $18M |
| INVESCO EXCHANGE TRADED FD T | NEW | +185.5K | 185.5K | +$17M | $17M |
| KVUEKENVUE INC | NEW | +554.5K | 554.5K | +$12M | $12M |
| TEVATEVA PHARMACEUTICAL INDS LTD | NEW | +268.5K | 268.5K | +$3M | $3M |
| COYACOYA THERAPEUTICS INC | ADDED | +806.0K | 1.27M | +$8M | $9M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2023 | $2.0B | 116 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.8B | 116 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $2.1B | 122 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.8B | 114 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.4B | 123 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.4B | 124 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.3B | 140 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.6B | 154 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.7B | 169 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.5B | 173 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.6B | 207 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.4B | 183 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.7B | 105 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.2B | 106 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $922M | 69 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $702M | 70 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.3B | 51 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.4B | 52 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.4B | 57 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.4B | 57 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $1.4B | 63 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 3 additional managers.
- DME Advisors, LP028-13228
- DME Capital Management, LP028-14000
- Greenlight Masters, LLC028-13259
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.